|
1
|
Borzio M, Dionigi E, Parisi G, Raguzzi I
and Sacco R: Management of hepatocellular carcinoma in the elderly.
World J Hepatol. 7:1521–1529. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mazzoccoli G, Tarquini R, Valoriani A,
Oben J, Vinciguerra M and Marra F: Management strategies for
hepatocellular carcinoma: Old certainties and new realities. Clin
Exp Med. 16:243–256. 2016. View Article : Google Scholar
|
|
3
|
Hoffmann EK and Lambert IH: Ion channels
and transporters in the development of drug resistance in cancer
cells. Philos Trans R Soc Lond B Biol Sci. 369:201301092014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ciccoli R, Sahi S, Singh S, Prakash H,
Zafiriou MP, Ishdorj G, Kock JL and Nigam S: Oxygenation by COX-2
(cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a
fungal mimetic of arachidonic acid, produces a cascade of novel
bioactive 3-hydroxyeicosanoids. Biochem J. 390:737–747. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chandrashekar N, Selvamani A, Subramanian
R, Pandi A and Thiruvengadam D: Baicalein inhibits pulmonary
carcinogenesis-associated inflammation and interferes with COX-2,
MMP-2 and MMP-9 expressions in-vivo. Toxicol Appl Pharmacol.
261:10–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esbona K, Inman D, Saha S, Jeffery J,
Schedin P, Wilke L and Keely P: COX-2 modulates mammary tumor
progression in response to collagen density. Breast Cancer Res.
18:352016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen G, Li X, Yang J, Li J, Wang X, He J
and Huang Z: Prognostic significance of cyclooxygenase-2 expression
in patients with hepatocellular carcinoma: A meta-analysis. Arch
Med Sci. 12:1110–1117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X,
Zhai HH, Zhang LH and Dou KF: Potential involvement of the
cyclooxygenase-2 pathway in hepatocellular carcinoma-associated
angiogenesis. Life Sci. 80:484–492. 2007. View Article : Google Scholar
|
|
9
|
Leng J, Han C, Demetris AJ, Michalopoulos
GK and Wu T: Cyclooxygenase-2 promotes hepatocellular carcinoma
cell growth through Akt activation: Evidence for Akt inhibition in
celecoxib-induced apoptosis. Hepatology. 38:756–768. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Galant LW, de Mattos AA, Menti E, Valiatti
FB, de Mattos AZ, Porawski M, Hartmann A and Rhoden CR: The effect
of celecoxib on the development of diethylnitrosamine-induced liver
tumors in rats. Ann Hepatol. 12:425–433. 2013.PubMed/NCBI
|
|
11
|
Sui W, Zhang Y, Wang Z, Wang Z, Jia Q, Wu
L and Zhang W: Antitumor effect of a selective COX-2 inhibitor,
celecoxib, may be attributed to angiogenesis inhibition through
modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22
murine hepatocarcinoma model. Oncol Rep. 31:2252–2260. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choe J, Yoon Y, Kim J and Jung YJ:
Positive feedback effect of PGE2 on cyclooxygenase-2 expression is
mediated by inhibition of Akt phosphorylation in human follicular
dendritic cell-like cells. Mol Immunol. 87:60–66. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Harbi NO, Imam F, Al-Harbi MM, Ansari
MA, Zoheir KM, Korashy HM, Sayed-Ahmed MM, Attia SM, Shabanah OA
and Ahmad SF: Dexamethasone attenuates LPS-induced acute lung
injury through inhibition of NF-κB, COX-2, and pro-inflammatory
mediators. Immunol Invest. 45:349–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Merk H, Zhang S, Lehr T, Muller C, Ulrich
M, Bibb JA, Adams RH, Bracher F, Zahler S, Vollmar AM and Liebl J:
Inhibition of endothelial Cdk5 reduces tumor growth by promoting
non-productive angiogenesis. Oncotarget. 7:6088–6104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang ZS, Chen LZ, Zhou HP, Liu XH and Chen
FH: Diarylpentadienone derivatives (curcumin analogues): Synthesis
and anti-inflammatory activity. Bioorg Med Chem Lett. 27:1803–1807.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hacker HJ, Steinberg P and Bannasch P:
Pyruvate kinase isoenzyme shift from L-type to M2-type is a late
event in hepatocarcinogenesis induced in rats by a
choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis.
19:99–107. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Christofk HR, Vander Heiden MG, Wu N,
Asara JM and Cantley LC: Pyruvate kinase M2 is a
phosphotyrosine-binding protein. Nature. 452:181–186. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung Y, Jang YJ, Kang MH, Park YS, Oh SJ,
Lee DC, Xie Z, Yoo HS, Park KC and Yeom YI: Metabolic signature
genes associated with susceptibility to pyruvate kinase, muscle
type 2 gene ablation in cancer cells. Mol Cells. 35:335–341. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong T, Yan Y, Chai H, Chen S, Xiong X,
Sun D, Yu Y, Deng L and Cheng F: Pyruvate kinase M2 affects liver
cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in
culture. Biomed Pharmacother. 69:277–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han D, Wei W, Chen X, Zhang Y, Wang Y,
Zhang J, Wang X, Yu T, Hu Q, Liu N and You Y: NF-κB/RelA-PKM2
mediates inhibition of glycolysis by fenofibrate in glioblastoma
cells. Oncotarget. 6:26119–26128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang M, Wang L, Chen J, Bai M, Zhou C,
Liu S and Lin Q: Regulation of COX-2 expression and
epithelial-to-mesenchymal transition by hypoxia-inducible
factor-1alpha is associated with poor prognosis in hepatocellular
carcinoma patients post TACE surgery. Int J Oncol. 48:2144–2154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG
and Qu Q: Edmondson-Steiner grade: A crucial predictor of
recurrence and survival in hepatocellular carcinoma without
microvascular invasio. Pathol Res Pract. 213:824–830. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Calderaro J, Couchy G, Imbeaud S, Amaddeo
G, Letouze E, Blanc JF, Laurent C, Hajji Y, Azoulay D, Bioulac-Sage
P, et al: Histological subtypes of hepatocellular carcinoma are
related to gene mutations and molecular tumour classification. J
Hepatol. 67:727–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Faria SC, Szklaruk J, Kaseb AO, Hassabo HM
and Elsayes KM: TNM/Okuda/Barcelona/UNOS/CLIP international
multidisciplinary classification of hepatocellular carcinoma:
Concepts, perspectives, and radiologic implications. Abdom Imaging.
39:1070–1087. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Yang HJ, Jiang JH, Yang YT, Yang XD, Guo
Z, Qi YP, Zeng FH, Zhang KL, Chen NZ, Xiang BD and Li LQ:
Cyclooxygenase-2 expression is associated with initiation of
hepatocellular carcinoma, while prostaglandin receptor-1 expression
predicts survival. World J Gastroenterol. 22:8798–8805. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim KN, Ko YJ, Yang HM, Ham YM, Roh SW,
Jeon YJ, Ahn G, Kang MC, Yoon WJ, Kim D and Oda T:
Anti-inflammatory effect of essential oil and its constituents from
fingered citron (Citrus medica L. var sarcodactylis) through
blocking JNK, ERK and NF-κB signaling pathways in LPS-activated RAW
2647 cells. Food Chem Toxicol. 57:126–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lou Y, Wang C, Zheng W, Tang Q, Chen Y,
Zhang X, Guo X and Wang J: Salvianolic acid B inhibits
IL-1β-induced inflammatory cytokine production in human
osteoarthritis chondrocytes and has a protective effect in a mouse
osteoarthritis model. Int Immunopharmacol. 46:31–37. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bu LJ, Yu HQ, Fan LL, Li XQ, Wang F, Liu
JT, Zhong F, Zhang CJ, Wei W, Wang H and Sun GP: Melatonin, a novel
selective ATF-6 inhibitor, induces human hepatoma cell apoptosis
through COX-2 downregulation. World J Gastroenterol. 23:986–998.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang JX, Xing JG, Wang LL, Jiang HL, Guo
SL and Liu R: Luteolin Inhibits Fibrillary β-Amyloid1-40-induced
inflammation in a human blood-brain barrier model by suppressing
the p38 MAPK-Mediated NF-κB signaling pathways. Molecules.
22:2017.
|
|
32
|
Ghosh S and Hayden MS: New regulators of
NF-κB in inflammation. Nat Rev Immunol. 8:837–848. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Z, Yang P and Li Z: The multifaceted
regulation and functions of PKM2 in tumor progression. Biochim
Biophys Acta. 1846:285–296. 2014.PubMed/NCBI
|
|
34
|
Hamaguchi Y, Mori A, Fujimoto Y, Ito T,
Iida T, Yagi S, Okajima H, Kaido T and Uemoto S: Longer warm
ischemia can accelerate tumor growth through the induction of
HIF-1α and the IL-6-JAK-STAT3 signaling pathway in a rat
hepatocellular carcinoma model. J Hepatobiliary Pancreat Sci.
23:771–779. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang CM, Chen YW, Chi PL, Lin CC and Hsiao
LD: Resveratrol inhibits BK-induced COX-2 transcription by
suppressing acetylation of AP-1 and NF-κB in human rheumatoid
arthritis synovial fibroblasts. Biochem Pharmacol. 132:77–91. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Radunz S, Treckmann J, Baba HA, Best J,
Muller S, Theysohn JM, Paul A and Benko T: Long-term outcome after
liver transplantation for hepatocellular carcinoma following
Yttrium-90 radioembolization bridging treatment. Ann Transplant.
22:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang
L, You MJ, Koh MY, Cote G, Aldape K, et al: EGFR-induced and
PKCepsilon monoubiquitylation-dependent NF-κB activation
upregulates PKM2 expression and promotes tumorigenesis. Mol Cell.
48:771–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xie W, Wang H, He Y, Li D, Gong L and
Zhang Y: CDK5 and its activator P35 in normal pituitary and in
pituitary adenomas: relationship to VEGF expression. Int J Biol
Sci. 10:192–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Magierowski M, Magierowska K,
Hubalewska-Mazgaj M, Sliwowski Z, Pajdo R, Ginter G, Kwiecien S and
Brzozowski T: Exogenous and endogenous hydrogen sulfide protects
gastric mucosa against the formation and time-dependent development
of ischemia/reperfusion-induced acute lesions progressing into
deeper ulcerations. Molecules. 22:pii: E2952017. View Article : Google Scholar
|
|
40
|
Wos J, Brys M, Lewy-Trenda I, Stasikowska
O, Papiez P, Papierz W and Starska K: Analysis of HIF-1α and COX-2
expression in tumor stroma and correlation with the degree of
neoplasm invasiveness in laryngeal cancer-preliminary study.
Otolaryngol Pol. 65:102–108. 2011.In Polish.
|
|
41
|
Tao T, Li G, Dong Q, Liu D, Liu C, Han D,
Huang Y, Chen S, Xu B and Chen M: Loss of SNAIL inhibits cellular
growth and metabolism through the miR-128-mediated
RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells.
Tumour Biol. 35:8543–8550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Salvolini E, Buldreghini E, Lucarini G,
Vignini A, Giulietti A, Lenzi A, Mazzanti L, Di Primio R and
Balercia G: Interleukin-1β, cyclooxygenase-2, and hypoxia-inducible
factor-1α in astheno-zoospermia. Histochem Cell Biol. 142:569–575.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao CX, Luo CL and Wu XH: Hypoxia
promotes 786-O cells invasiveness and resistance to sorafenib via
HIF-2α/COX-2. Med Oncol. 32:4192015. View Article : Google Scholar
|
